Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in unresectable pancreatic neuroendocrine tumors (post‑marketing, China cohort)
CTR20140783Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sunitinib in islet cell tumor, sponsored by Pfizer. Started Jan 2015; status: completed.
02
Drugs
sunitinib
03
Conditions
islet cell tumor
Beyond the preview
Go deeper on CTR20140783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140783.